Radiothérapie stéréotaxique : changement de monde ou effet de mode ?
| Autor: | Amel Rehailia-Blanchard, Omar Jmour, Nicolas Magné, Alexis Vallard, Jane-Chloé Trone, Nicolas Vial, Sandrine Sotton, Elisabeth Daguenet, Jean-Baptiste Guy |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
0301 basic medicine
Cancer Research medicine.medical_specialty business.industry medicine.medical_treatment Abscopal effect Hematology General Medicine medicine.disease Immune therapy Radiation therapy 03 medical and health sciences 030104 developmental biology 0302 clinical medicine Survival benefit Oncology 030220 oncology & carcinogenesis medicine Degree of precision Radiology Nuclear Medicine and imaging Radiology Non small cell Lung cancer business Stereotactic body radiotherapy |
| Zdroj: | Bulletin du Cancer. 107:244-253 |
| ISSN: | 0007-4551 |
| DOI: | 10.1016/j.bulcan.2019.09.011 |
| Popis: | Stereotactic body radiotherapy (SBRT) is a young technology that can deliver a high dose of radiation to the target, utilizing either a single dose or a small number of fractions with a high degree of precision within the body. Various technical solutions co-exist nowadays, with particular features, possibilities and limitations. Health care authorities have currently validated SBRT in a very limited number of locations, but many indications are still under investigation. It is therefore challenging to accurately appreciate the SBRT therapeutic index, its place and its role within the anticancer therapeutic arsenal. The aim of the present review is to provide SBRT definitions, current indications, and summarize the future ways of research. There are three validated indications for SBRT: un-resecable T1-T2 non small cell lung cancer |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|